A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.
about
Radiofrequency ablation in the treatment of liver metastases from colorectal cancerResection versus no intervention or other surgical interventions for colorectal cancer liver metastasesIs There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?Designing liver resections and pushing the envelope with resections for hepatic colorectal metastasesFIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATIONLocoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.Multidisciplinary approach of colorectal cancer liver metastases.Image-guided percutaneous ablation of hepatic malignancies.Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal.Colorectal hepatic metastasis: Evolving therapies.Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastasesOptimal management of colorectal liver metastases in older patients: a decision analysis.Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer.Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013Liver resection for colorectal cancer metastases.Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases.Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer.Surgical treatment for liver cancer.Radiofrequency ablation of colorectal hepatic metastases.Surgical treatment of hepatic metastases from colorectal cancer.Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin.Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.Understanding the current status of image-guided ablation for metastatic colorectal disease.Advances in understanding of colorectal liver metastasis and implications for the clinic.Liver-directed therapies in metastatic colorectal cancer.Distant Liver Metastases as a Major Factor Influencing Survival in Patients with Colorectal Cancer.Doppler signals observed during high temperature thermal ablation are the result of boiling.Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence.Quality improvement guidelines for radiofrequency ablation of liver tumours.Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies.Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy.CT-guided high-dose-rate brachytherapy of liver tumours does not impair hepatic function and shows high overall safety and favourable survival rates.Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases.CT-guided radiofrequency ablation following high-dose chemotherapy of a liver-metastasizing pancreatoblastoma with tumor thrombus in the portal vein.A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resectionThe Role of Liver-Directed Therapy in Metastatic Colorectal Cancer
P2860
Q24202637-AED86AB4-3220-4159-8DFC-96BBA60E7CE8Q24243003-E3239012-B4B3-41DB-BDA1-3BD9074B0AFAQ26796522-515B3FE6-530D-4F40-B53F-ABEB5A20A5C6Q26864128-EF31253D-F6CA-49A5-B91C-701D03E636EDQ28066171-4896C47A-7C84-49F8-A5B6-6FD566E6AC82Q30415022-88C5D154-09AD-4003-8075-958DBAF4A14FQ33614301-16519D1D-C4CE-405E-B9B9-2688E86A3618Q33779859-DF147D89-0A29-4087-8D40-5853C73CE28FQ33832472-4ABDFFD7-940F-4207-9EA1-83CCE8F349ECQ33906344-8DA46782-782E-4F6C-B2C0-C33CCFC39E46Q34663557-E7AB2447-0913-408D-9E84-E00327FB88B4Q34873168-F36D769A-3DA8-4F3E-B0DD-E1EDB431D267Q35805877-D4B1B600-09DB-4708-804A-E6A58413464AQ35995438-566FE1AD-82F7-4788-B357-39D1768E7A53Q36258276-7F0058D8-4E5C-43C5-B1A2-9913982043BEQ36897808-610C75E0-913D-4239-8F22-1B67EB021107Q37308725-EBFC8412-EAEB-4080-8453-ED441DC6A42CQ37427913-8A9028D6-8421-46C7-BFCF-844484137370Q37652110-A3696AF0-D218-44DA-970E-0FC1BA58323EQ37697708-553820E8-7AE3-4C9A-AFD6-764A097BE471Q37821852-20FF3333-FE7C-4583-BB76-B41A313D438BQ37832394-C6D90171-9DDA-43B9-9427-71C0673F79A2Q37857524-A35A8253-E27B-4040-99B2-E145280C60BDQ37889187-5081029D-E59E-4BD5-B6B1-7CEF532D94B7Q37995052-8C507FC4-9399-4CCF-A022-2380E1A8EA78Q38114316-9E4DABF9-49AE-4A24-A7EB-EDFF2DBB7580Q38230654-24F3401C-FBC2-4FF1-ADFE-094A699EFC1CQ38256165-66DC4CBD-F985-48DC-B69B-84BF6C4EB889Q40530780-A1ADA226-D7FB-4E4D-9556-000313633402Q41910498-BF62C431-9E11-4CD3-867E-3C46C806C246Q42590895-3F3CBC45-8630-4E95-A367-554498FF9BF7Q42922856-46C32272-99EC-4D84-A060-86826549E337Q43413801-5EE47830-0327-48EA-BC36-69A9BCBFFFBFQ46978282-379E44F9-7511-4A86-8E90-77F4B8EA89EBQ50324017-12CB0561-1549-4C35-9CF8-FD6C2E116BFDQ50454379-92AD266E-AB35-4D1C-B456-405DD4D6E1BBQ52922107-B5E4FBBC-7798-460B-BE6F-89CFFDA4792BQ53102905-DE2C072B-929B-4E92-98FB-AC244627E2FFQ57088820-8D8A41D3-AFD2-434F-A2F0-A7E970698498Q57193222-BD89275C-9F0C-4496-BF50-76AFD193186F
P2860
A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A systematic review on the cli ...... f colorectal liver metastases.
@en
A systematic review on the cli ...... f colorectal liver metastases.
@nl
type
label
A systematic review on the cli ...... f colorectal liver metastases.
@en
A systematic review on the cli ...... f colorectal liver metastases.
@nl
prefLabel
A systematic review on the cli ...... f colorectal liver metastases.
@en
A systematic review on the cli ...... f colorectal liver metastases.
@nl
P2093
P1476
A systematic review on the cli ...... of colorectal liver metastases
@en
P2093
Axel Stang
Carsten Bokemeyer
Dietrich Braumann
Wolfgang Teichmann
P304
P356
10.1016/J.EJCA.2009.03.012
P577
2009-04-06T00:00:00Z